Keytruda Market Analysis: Unveiling the Immunotherapy Landscape
The Keytruda Market analysis reveals a rapidly evolving immunotherapy sector, fueled by increasing cancer prevalence and an enhanced understanding of checkpoint inhibitors. Keytruda, a PD-1 inhibitor developed by Merck & Co., has gained approval for multiple cancer types, including non-small cell lung cancer, head and neck...
Bangla